StockData
MIRA Pharmaceuticals, Inc. logo

MIRA Pharmaceuticals, Inc. (MIRA) stock

MIRANasdaqPharmaceutical Preparations
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026Score 6/30
$0.37−0.22 (-37.68%)

Close on Nov 19, 2026Market cap $15.48MP/E –Yield –

MIRA Pharmaceuticals total assets

Total assets on the balance sheet at the end of each period.

MIRA Pharmaceuticals's total assets was $8.20M at Jun 30, 2026. For fiscal 2025 it was $11.09M, up 279.5% from the year before.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$11.09M+279.5%
FY2024Dec 31, 2024$2.92M-40.7%
FY2023Dec 31, 2023$4.93M+474.8%
FY2022Dec 31, 2022$858.07K–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$8.20M+844.7%
Q1 FY2026Mar 31, 2026$9.46M+575.8%
Q4 FY2025Dec 31, 2025$11.09M+279.5%
Q3 FY2025Sep 30, 2025$7.63M+78.9%
Q2 FY2025Jun 30, 2025$868.32K-71.2%
Q1 FY2025Mar 31, 2025$1.40M-63.2%
Q4 FY2024Dec 31, 2024$2.92M-40.7%
Q3 FY2024Sep 30, 2024$4.27M-52.7%
Q2 FY2024Jun 30, 2024$3.02M-21.2%
Q1 FY2024Mar 31, 2024$3.81M+343.9%
Q4 FY2023Dec 31, 2023$4.93M–
Q3 FY2023Sep 30, 2023$9.02M–
Q2 FY2023Jun 30, 2023$3.83M–
Q4 FY2022Dec 31, 2022$858.07K–

More MIRA Pharmaceuticals figures

See a number that looks wrong?